You searched for London - Page 18 of 35

News and Trends 18 May 2017

Heptares receives €4.5M Milestone for New Migraine Drug Candidate

The UK biotech attacking notoriously evasive GPCRs has discovered a small molecule that could be used to treat migraine headaches. Heptares, owned by Sosei and based just outside London, will…

May 18, 2017 - 1 minutemin - By Evelyn Warner

News and Trends 7 Jul 2019

European Biotech: The Insider View

…each other. “We are ‘frenemies’ with a big ‘fre-’ at the front,” said Giovanni Mariggi, Partner at London-based VC firm Medicxi. “We’re all part of the ecosystem and must find…

July 7, 2019 - 10 minutesmins - By Jonathan Smith

News and Trends 26 Oct 2022

New UK spinout VacV Biotherapeutics emerges from stealth to work on cancer immunotherapies

…has spun out of Barts Cancer Institute and Queen Mary University of London following 20 years of research by immunotherapy experts Yaohe Wang, Nicholas Lemoine, and their team of cell…

October 26, 2022 - 2 minutesmins - By Jim Cornall

coronavirus COVID 19 Europe biotech lungs

News and Trends 22 Jul 2020

Inhaled Treatment Reduces Severe Covid-19 Risk by 79%

…Covid-19 vaccines developed by AstraZeneca and the University of Oxford and by Pfizer and BioNTech showed promising interim clinical results in phase I, while Imperial College London reported that its…

July 22, 2020 - 3 minutesmins - By Victor Kotsev

News and Trends 9 Aug 2022

Asthma in the spotlight as Upstream Bio starts trial and UK universities propose new long-term treatment

…the first patient. Meanwhile, a possible way to tackle one of the underlying causes of asthma has been developed by researchers from Aston University and Imperial College London in the…

August 9, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 11 Jul 2023

NodThera first to show reduction in neuroinflammation with inflammasome inhibitor

…of Medicine of Imperial College London, said: “These data, while still very preliminary, provide promising evidence of the potential of NLRP3 inhibition to modulate the neuroinflammation associated with Parkinson’s disease….

July 11, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 28 Jun 2022

Eiger BioPharmaceuticals presents liver study data

…at the European Association for the Study of the Liver (EASL) International Liver Congress 2022 that took place June 22-26 in London, U.K. David Cory, president and CEO of Eiger,…

June 28, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 31 Jan 2018

Gene Synthesizing Biotech Gets $12M to Boost the Synbio Field

…round, which was led by Californian investor DCVC and London-based VC Draper Esprit. Evonetix’s high-throughput, highly accurate DNA synthesis technology will allow the company to make a claim for a…

January 31, 2018 - 3 minutesmins - By Alex Dale

News and Trends 15 May 2018

An Epigenetic Drug for Prostate Cancer Gets $26M to Enter Clinical Trials

…Hospital in London and then extended to the US. CellCentric sees potential for the epigenetic drug to work in other types of cancer, especially those with mutations of the p300…

May 15, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Dec 2020

Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference

…hematological cancer, as usual, received much of the attention of the conference. Among the highlights, the London-based company Autolus Therapeutics released data from a phase I/II clinical study showing that…

December 17, 2020 - 6 minutesmins - By Victor Kotsev

In Depth 17 Oct 2022

UK grants that can give biotech startups a vital jump-start

…outside of the U.K.’s Golden Triangle region that includes Oxford, Cambridge and London, there are also ways to pitch how your company can align with the Levelling Up agenda established…

October 17, 2022 - 7 minutesmins - By Jonathan Smith

Jennie Ekbeck Umea Biotech Incubator e1575383377248

Interview 25 Nov 2019

Building a Life Science Industry from Scratch in a Small Swedish Town

…the icebergs, so it’s quite challenging to develop these types of ideas when you’re so far away from hotspots like London, the Netherlands, Germany… places where you have so many…

November 25, 2019 - 8 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: London

Heptares receives €4.5M Milestone for New Migraine Drug Candidate

European Biotech: The Insider View

New UK spinout VacV Biotherapeutics emerges from stealth to work on cancer immunotherapies

Inhaled Treatment Reduces Severe Covid-19 Risk by 79%

Asthma in the spotlight as Upstream Bio starts trial and UK universities propose new long-term treatment

NodThera first to show reduction in neuroinflammation with inflammasome inhibitor

Eiger BioPharmaceuticals presents liver study data

Gene Synthesizing Biotech Gets $12M to Boost the Synbio Field

An Epigenetic Drug for Prostate Cancer Gets $26M to Enter Clinical Trials

Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference

UK grants that can give biotech startups a vital jump-start

Building a Life Science Industry from Scratch in a Small Swedish Town

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!